Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds.

Popular weight loss drugs like Ozempic might be able to help with substance abuse, according to new research on people addicted to opioids and alcohol. Routine checkups for Brandon Downey, a South Jersey nurse who's taking Wegovy to lose weight, show a positive trend.

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, thigh or stomach. They work as an appetite suppressant by mimicking a hormone called glucagon-like peptide-1 (GLP-1).

Novo Nordisk, the pharmaceutical company behind the world’s most popular weight-loss injections, is expanding its global market. Wegovy is already available in five other European countries, including Norway,

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on euronews

Weight-loss drugs might help people battle addictions. Alcoholics taking GLP-1 drugs had a 50% lower rate of intoxication. Opioid users taking the drugs had a 40% lower risk of ov

A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds Ozempic, Wegovy, Mounjaro or Zepbound, may help users overcome alcoholism and opioid addiction.

Weight loss medications such as Ozempic may be able to cut drug and alcohol misuse in half, according to a new study from the scientific journal Addiction. The research, published Thursday, found that people who take Ozempic or similar drugs — those used for weight loss or treating Type 2 diabetes — were 40